USPHU.S. Physical Therapy, Inc.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at U.S. Physical Therapy (NYSE:USPH) and its peers.

Record visit volumes offset by employee healthcare cost pressures in latest quarter.

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

U.S. Physical Therapy (NYSE:USPH) reported second-quarter 2026 revenue growth supported by higher patient volumes, improved reimbursement rates and the early rollout of hospital-affiliation agreements, while elevated employee healthcare claims and upfront staffing costs pressured physical therapy ma

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]

US Physical Therapy Inc (USPH) posts record Q2 visits per clinic, raises 2025 EBITDA guidance to $93-$97 million, and sees first positive Medicare rate outlook in years.

Moby summary of U.S. Physical Therapy, Inc.'s Q2 2026 earnings call

U.S. Physical Therapy (USPH) reported mixed second quarter 2026 results, with higher revenue alongside lower net income and earnings per share, and separately affirmed a quarterly dividend of $0.46 per share. See our latest analysis for U.S. Physical Therapy. The latest earnings and dividend announcement comes after a strong 90 day share price return of 31.71%. However, the year to date share price return is slightly down 1.48% and the 3 year total shareholder return is down 23.95%. This...

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of -11.77% and +0.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The headline numbers for U.S. Physical Therapy (USPH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 16.6% over the past six months, topping the S&P 500 by 9.6 percentage points.

Option Care (OPCH) delivered earnings and revenue surprises of +7.14% and +1.68%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at U.S. Physical Therapy (NYSE:USPH) and its peers.